SCHEMBL533064

SCHEMBL533064

Cc1ccccc1C(=O)Nc1c(C)cc(C)c(N2CCCC2)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.56
ALDH1A1 P00352 5/20 0.56
GAA P10253 5/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
L3MBTL1 Q9Y468 3/20 0.56
MAPK1 P28482 3/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
ATM Q13315 1/20 0.56
BRPF1 P55201 1/20 0.51
KMT2A Q03164 4/20 0.48
LMNA P02545 2/20 0.48
HPGD P15428 1/20 0.46
MEN1 O00255 2/20 0.45
RXFP1 Q9HBX9 3/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532983 0.91 MAPT (0.46) MAPTALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL533116 0.90 MAPT (0.46) MAPTALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL534076 0.90 POLB (0.53) MAPTALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL532950 0.89 KMT2A (0.56) MAPTALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL532801 0.89 GAA (0.48) MAPTALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL532964 0.89 L3MBTL1 (0.47) MAPTALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL532973 0.88 MAPT (0.44) MAPTALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL533434 0.88 ALDH1A1 (0.44) MAPTALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL8321708 0.88 ALDH1A1 (0.46) MAPTALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL533009 0.87 ALDH1A1 (0.44) MAPTALDH1A1GAASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed